Tissue inhibitor of metalloproteinases-1 protects the human breast carcinoma cell line MCF-7 S1 against anthracycline-induced cell death by activation of the akt survival pathway.
1999 ◽
Vol 58
(2)
◽
pp. 273-278
◽
1998 ◽
Vol 4
(6)
◽
pp. 409-419
◽
1976 ◽
Vol 56
(2)
◽
pp. 279-280
◽
1986 ◽
Vol 25
(6)
◽
pp. 973-979
◽
2011 ◽
Vol 26
(6)
◽
pp. 539-551
◽
1997 ◽
Vol 63
(4-6)
◽
pp. 275-281
◽